Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom
*** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical
NHS
*** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical